Additionally, irbesartan in HF mildly reduced EF/HFpEF (I-PRESERVE) showed a progressive increase in morbidity and mortality with increasing plasma concentrations of NT-proBNP, but the medication did not improve overall prognosis [38]. Here, NPPB is linked to hydrops fetalis.